Amphastar Pharmaceuticals, Inc. (AMPH) stock
AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3030% below fair value
$29.37+0.50 (+1.73%)
Close on Nov 13, 2026Market cap $1.25BP/E 13.3Yield –
Amphastar Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Amphastar Pharmaceuticals's pe ratio was 16.8× on Nov 11, 2026, against 12.3× a year earlier. Over the last 5 years it ranged from 7.6× to 33.9×, with a median of 16.1×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 16.8× | +5.0 |
| 2025 | Dec 31, 2025 | 11.8× | −0.5 |
| 2024 | Dec 31, 2024 | 12.4× | −11.8 |
| 2023 | Dec 29, 2023 | 24.2× | +5.4 |
| 2022 | Dec 30, 2022 | 18.8× | −13.5 |
| 2021 | Dec 31, 2021 | 32.3× | −111.3 |
| 2020 | Dec 31, 2020 | 143.6× | +125.3 |
| 2019 | Dec 31, 2019 | 18.4× | −220.3 |
| 2018 | Apr 30, 2018 | 238.6× | +12.8 |
| 2017 | Oct 31, 2017 | 225.9× | +184.0 |
| 2016 | Dec 30, 2016 | 41.9× | −0.4 |
| 2014 | Jul 31, 2014 | 42.3× | – |
See a number that looks wrong?